Provided by Tiger Trade Technology Pte. Ltd.

Bristol-Myers Squibb

61.46
-0.9400-1.51%
Post-market: 61.680.2214+0.36%19:59 EDT
Volume:10.77M
Turnover:663.45M
Market Cap:125.12B
PE:13.53
High:62.61
Open:62.20
Low:61.25
Close:62.40
52wk High:68.64
52wk Low:42.52
Shares:2.04B
Float Shares:2.03B
Volume Ratio:0.76
T/O Rate:0.53%
Dividend:2.51
Dividend Rate:4.08%
EPS(TTM):4.54
EPS(LYR):3.46
ROE:46.60%
ROA:10.72%
PB:5.61
PE(LYR):17.76

Loading ...

Bristol Myers Squibb Co. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Sep 26

Bristol-Myers Squibb Says Zenbexus Combination Doubles MRD-Negative Complete Response in Multiple Myeloma Trial

MT Newswires Live
·
Sep 25

Bristol Myers reports results from prespecified analysis of EXCALIBER-RRMM trial

TIPRANKS
·
Sep 25

Bristol Myers Squibb Wins FDA Accelerated Approval for Zenbexus Combo in Multiple Myeloma

Reuters
·
Sep 25

Bristol Myers Squibb Announces First Presentation of Results for Zenbexus™ (Iberdomide) in Combination with Daratumumab from Phase 3 Excaliber-Rrmm Trial in Relapsed or Refractory Multiple Myeloma

THOMSON REUTERS
·
Sep 25

BMY’s Lung Cancer Combo Study Completion Adds Quiet Support to Its Immuno-Oncology Pipeline

TIPRANKS
·
Sep 25

Pharmaceutical Stocks Jump. Moderna, Eli Lilly up over 3%; Novavax, Pfizer up Around 2%; Merck, Novo Nordisk up over 1%

Tiger Newspress
·
Sep 24

RBC Capital Sticks to Their Hold Rating for Bristol-Myers Squibb (BMY)

TIPRANKS
·
Sep 24

Bristol Myers Squibb Co. Stock Underperforms Wednesday When Compared to Competitors

Dow Jones
·
Sep 24

Biokin Pharma Triggers Second $250 Million Milestone from Bristol Myers Squibb Deal; Shares Down 4%

MT Newswires Live
·
Sep 22

Travere Therapeutics Names Bradley Campbell CEO, Effective Dec. 1, 2026

Reuters
·
Sep 22

Pharma Sector Doubles Down on AI to Slash Costs, Timelines

Reuters
·
Sep 21

Sichuan Biokin Pharmaceutical Says Unit Received $250 Mln Milestone Payment from Bristol-Myers Squibb for Iza-Bren Agreement

THOMSON REUTERS
·
Sep 21

Bloomsbury Publishing (BMY) Gets a Buy from Berenberg Bank

TIPRANKS
·
Sep 18

Bristol Myers Squibb to Report Q3 Results, Host Earnings Call

Reuters
·
Sep 18

Bristol Myers Squibb to Report Results for Third Quarter 2026 on October 29, 2026

THOMSON REUTERS
·
Sep 18

Bristol-Myers Squibb Announces R$ 2.15-Per-Unit Dividend for Q4 2026

Reuters
·
Sep 18

Bristol Myers Squibb Co. Stock Underperforms Thursday When Compared to Competitors

Dow Jones
·
Sep 18

Bristol Myers Squibb Reports Sustained Sotyktu Responses in Psoriatic Arthritis Through 2 Years

MT Newswires Live
·
Sep 17

Bristol Myers Squibb Presents Sotyktu (Deucravacitinib) Data Showing Durable Efficacy, Consistent Safety in Adults with Psoriatic Arthritis over Two Years

THOMSON REUTERS
·
Sep 17